MedTech News
.................... by Andrew Celentano
Creating a wireless tissue-aware medical device network in the human body
A research group led by Associate Professor Takumi Kobayashi and Professor Daisuke Anzai at the Graduate School of Informatics, Osaka Metropolitan University, focused on optimizing signal transmission separately for each frequency, allowing multiple implants to coordinate their signals using ultra-wideband (UWB) communication.
AI can use a photo of the eye to estimate retinal age, flag risk for major diseases
A research group led by Professor Toru Nakazawa at the Tohoku University Graduate School of Medicine has developed an artificial intelligence (AI) model that estimates “retinal age,” an indicator reflecting an individual’s biological aging, from a single fundus photograph of the retina
Plug-and-play AI recognizes 18 cancer types from just a handful of slides
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial intelligence (AI) pathology analysis system that can accurately recognize multiple types of cancer using only a minimal number of samples.
This bioengineered chewing gum wipes out cancer-linked mouth microbes while sparing healthy bacteria
Researchers led by Henry Daniell of the School of Dental Medicine have shown that extracts from bioengineered chewing gum reduce the levels of three microbes known to be associated with head and neck squamous cell cancer (HNSCC), paving the way for more effective and affordable therapies.
FDA Approves Expanded Clinical Applications for SINEFIX™ in Soft Tissue Repair
Broader indications reinforce SINEFIX as a versatile alternative to traditional suture anchors for soft tissue-to-bone fixation.
Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients
EXETER, N.H., April 21, 2026 /PRNewswire/ — Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient Circuit (APC™) which now includes therapy settings for neonatal and infant patients. The cleared APC enables the HVT 2.0 high velocity therapy system to deliver therapy across a 2–45 L/min flow range using a single disposable patient circuit.
Hyalex Orthopaedics Announces FDA 510(k) Clearance of the HYALEX Slalom™ MTP Hemiarthroplasty System
LEXINGTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) — Hyalex Orthopaedics today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HYALEX Slalom™ MTP Hemiarthroplasty Implant, a next-generation implant designed around the proprietary Hydrosurf™ materials platform, for the treatment of degenerative conditions affecting the first metatarsophalangeal (MTP) joint, including hallux rigidus.
Implanted nerve stimulation for obstructive sleep apnea found to be safe and effective
Researchers conducted the OSPREY (treating Obstructive Sleep aPnea using taRgEted hYpoglossal nerve stimulation) trial to better understand the safety and efficacy of pHGNS.